Feng Zhang runs the Zhang Lab at the Massachusetts Institute of Technology. He's also a faculty member at the Broad Institute of MIT and Harvard, and has co-founded several biotech companies, including Editas Medicine. His conversation with Nature Biotechnology covers immigrating to America as a boy, his moment of discovery with CRISPR, and what massive success before the age of 35 does to a researcher.
Rights and permissions
About this article
Cite this article
PODCAST: First rounders: Feng Zhang. Nat Biotechnol 36, 784 (2018). https://doi.org/10.1038/nbt0918-784
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0918-784
